Chong Kun Dang Smart Factory Pharmaceutical Bio Open House Completion...Planning Program of the Korea Pharmaceutical Bio Association
Jul 28, 2025
|
A total of 80 people attended the event, which was held at Chong Kun Dang Smart Factory in Cheonan, Chungcheongnam-do, on the 17th and 25th, including officials from related organizations such as the Ministry of Health and Welfare, the Ministry of Food and Drug Safety, the Korea Food and Drug Safety Evaluation Institute, the Korea Health Industry Promotion Agency, and the Fair Competition Protocol Review Committee.
Participants toured the state-of-the-art 'Smart Factory' of the Chong Kun Dang Cheonan plant, and directly identified innovation cases at pharmaceutical manufacturing sites through explanations and Q&As on process innovation systems based on digital transformation and artificial intelligence (AI).
Chong Kun Dang has established a smart factory with the aim of strengthening global pharmaceutical manufacturing competitiveness through digital transformation. This smart factory consists of three pillars: ▲ prediction-based process and quality management ▲ AI-based quality management ▲ AI-based facility operation. Through this, advanced technologies such as real-time optimization of manufacturing processes, automation of annual product quality assessment (APQR), predictive preservation that detects and maintains abnormal signs of facilities in advance, and intelligent CCTV are in operation.
Meanwhile, with the Chong Kun Dang event, the 'Pharmaceutical Bio Open House' program organized by the association since April was successfully completed. The program, which was organized to mark the 80th anniversary of its foundation, was designed to enhance public and policy officers' understanding of the pharmaceutical bio industry. Starting with Korea Germany, a total of six companies participated, including Inist ST, Daewon Pharmaceutical, HK Innoen, GC Green Cross, and Chong Kun Dang. It was conducted in the form of a tour of each company's production facilities and research facilities, and the cumulative participants amounted to about 230 people from eight governments and public institutions, including the Ministry of Health and Drug Safety, the Health Insurance Corporation, and the Simpyeongwon.
Roh Yeon-hong, Chairman of the Korea Pharmaceutical and Bio Association, said "This open house served as a bridge between policy and inter-industry communication by sharing the field, technology, and future strategies of the pharmaceutical industry"We will continue to expand the field of practical exchanges that can enhance mutual understanding and cooperation between industry and policy authorities in the future."
This article was translated by Naver AI translator.
